Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) EPS (Basic) (2023 - 2026)

Updated

Adaptin Bio's EPS (Basic) came in at -$0.14 for Q2 2026, compared with -$0.18 a year earlier.

Analysis

Adaptin Bio (APTN) EPS (Basic) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Adaptin Bio reported EPS (Basic) of -$0.61; for FY2025, it came in at -$0.66.

  • Going back by year, EPS (Basic) was -$0.62 in FY2024, -$0.02 in FY2023 and -$0.01 in FY2022.
  • The five-year range for quarterly EPS (Basic) is -$0.22 (Q3 2024) to -$0.01 (Q4 2023).
  • Business Quant data shows APTN's EPS (Basic) at -$0.13 (Q1 2026), -$0.18 (Q4 2025) and -$0.20 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.30
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.04
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -0.54
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 1.68
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.87
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 4.34
10 Adaptin Bio 56.76 Mn 54.75 Mn - -0.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.14
Mar 31, 2026 -0.13
Dec 31, 2025 -0.18
Sep 30, 2025 -0.20
Jun 30, 2025 -0.18
Mar 31, 2025 -0.10
Dec 31, 2024 -0.17
Sep 30, 2024 -0.22
Jun 30, 2024 -0.16
Mar 31, 2024 -0.07
Dec 31, 2023 -0.01
Sep 30, 2023 -0.01
API Access

Adaptin Bio EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=APTN&period=max&api_key=YOUR_API_KEY